V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 320007226 | 320003422 | 1.7 | 54 | Adjuvant (A) | 2017-05-06 | 2017-07-21 | Cisplatin + Radiotherapy | 2 | N | 320015262 | CISPLATIN + RT |
| 320007227 | 320003427 | 1.63 | 54 | Adjuvant (A) | 2017-12-06 | 2017-12-06 | Cisplatin 100 + RT(H&N) 1 day | N | Y | 320015290 | CISPLATIN + RT |
| 320007228 | 320005562 | 1.74 | null | Palliative (P) | 2014-05-06 | 2014-06-04 | CISPLATIN + FLUOROURACIL | N | N | 320015336 | CISPLATIN + FLUOROURACIL |
| 320007229 | 320005565 | 1.74 | 83.4 | Palliative (P) | 2018-11-01 | 2018-11-16 | Liposomal Doxorubicin (Caelyx) | 02 | N | 320015363 | LIPOSOMAL DOXORUBICIN |
| 320007230 | 320003463 | 1.8 | 25.4 | Palliative (P) | 2017-07-10 | 2017-07-12 | GEMCARBO | 02 | N | 320015469 | GEMCARBO |
| 320007231 | 320003473 | 1.65 | 72.9 | Curative (C) | 2016-04-12 | 2016-05-28 | Cisplatin + Radiotherapy | 2 | N | 320015567 | CISPLATIN + RT |
| 320007232 | 320005579 | 1.68 | 76.8 | null | 2019-01-08 | 2019-01-27 | Carboplatin + Liposomal Doxorubicin | 2 | N | 320015586 | CARBOPLATIN + LIPOSOMAL DOX |
| 320007233 | 320003480 | 1.76 | 94.6 | null | 2016-04-07 | 2016-04-29 | Cisplatin +Fluorouracil (3 wk) | N | N | 320015612 | CISPLATIN + FLUOROURACIL |
| 320007234 | 320003485 | 1.74 | 85 | Palliative (P) | 2018-03-09 | 2018-03-16 | Trial Unspecified | 02 | null | 320015665 | TRIAL |
| 320007235 | 320006594 | 1.82 | 86.2 | Palliative (P) | 2016-06-19 | 2016-06-20 | CARBOPLATIN + GEMCITABINE | N | N | 320015740 | GEMCARBO |
| 320007236 | 320003509 | 1.66 | 79 | Palliative (P) | 2015-10-05 | 2015-10-06 | GemCarbo Days 1+8 | N | Y | 320015806 | GEMCARBO |
| 320007237 | 320003512 | null | 64.8 | Palliative (P) | 2017-10-13 | 2017-11-13 | Liposomal Doxorubicin 40mg/m2 | 02 | N | 320015815 | LIPOSOMAL DOXORUBICIN |
| 320007238 | 320003519 | 1.78 | null | Palliative (P) | 2018-04-22 | 2018-04-27 | Cetuximab 7 day (Cycle 1) | N | Y | 320015848 | CETUXIMAB |
| 320007239 | 320003555 | 1.75 | 76.8 | Curative (C) | 2018-08-15 | 2018-08-15 | Trial Unspecified | 02 | N | 320016065 | TRIAL |
| 320007240 | 320003558 | 1.7 | 82.3 | Palliative (P) | 2016-12-30 | 2017-01-01 | Cetuximab 7 day (>Cycle 2) | 2 | Y | 320016072 | CETUXIMAB |
| 320007241 | 320003565 | 1.53 | 71.6 | Palliative (P) | 2015-12-12 | 2015-12-12 | CISPLATIN + FLUOROURACIL | N | N | 320016194 | CISPLATIN + FLUOROURACIL |
| 320007242 | 320003571 | 0 | 59.1 | Palliative (P) | 2014-09-19 | 2015-03-04 | GEMCARBO | N | N | 320016272 | GEMCARBO |
| 320007243 | 320003575 | 1.72 | 85.1 | null | 2018-07-23 | 2018-07-23 | Trial Unspecified | N | N | 320016288 | TRIAL |
| 320007244 | 320003601 | 1.87 | 78.4 | Palliative (P) | 2014-10-20 | 2015-05-05 | Carboplatin + Liposomal Doxorubicin | N | N | 320016701 | CARBOPLATIN + LIPOSOMAL DOX |
| 320007245 | 320003607 | null | 83.5 | Palliative (P) | 2018-05-24 | 2018-05-25 | Liposomal Doxorubicin (Caelyx) | 2 | N | 320016767 | LIPOSOMAL DOXORUBICIN |
| 320007246 | 320005650 | 1.79 | 64.8 | Palliative (P) | 2018-11-14 | 2019-04-11 | Cetuximab 14 day | 02 | N | 320016797 | CETUXIMAB |
| 320007247 | 320003627 | 1.68 | 118.4 | Palliative (P) | 2015-01-27 | 2015-06-29 | Cetuximab 7 day (Cycle 1) | Y | N | 320017094 | CETUXIMAB |
| 320007248 | 320003642 | 1.63 | 54.5 | Curative (C) | 2016-06-07 | 2018-01-07 | Cisplatin + Radiotherapy | N | N | 320017245 | CISPLATIN + RT |
| 320007249 | 320005668 | null | 83 | Palliative (P) | 2015-08-17 | 2015-12-25 | Cetuximab 7 day (>Cycle 2) | N | N | 320017254 | CETUXIMAB |
| 320007250 | 320003652 | 1.68 | 103 | Palliative (P) | 2018-02-22 | 2018-03-17 | CARBOPLATIN + GEMCITABINE | 02 | N | 320017319 | GEMCARBO |
| 320007251 | 320003659 | null | 115 | Neo-adjuvant (N) | 2017-02-28 | 2017-07-04 | CNS LGG 2004 03 cons vinc + carbo | null | null | 320017403 | NOT MATCHED |
| 320007252 | 320003666 | 1.68 | null | Palliative (P) | 2016-03-16 | 2016-03-17 | Cisplatin +Fluorouracil (2 wk) | N | N | 320017443 | CISPLATIN + FLUOROURACIL |
| 320007253 | 320003672 | 1.62 | 90.5 | Palliative (P) | 2016-06-20 | 2016-07-04 | CISPLATIN + FLUOROURACIL | Y | N | 320017521 | CISPLATIN + FLUOROURACIL |
| 320007254 | 320003678 | 1.79 | 78.55 | Palliative (P) | 2016-03-26 | 2016-04-09 | CETUXIMAB | 02 | N | 320017615 | CETUXIMAB |
| 320007255 | 320003687 | 1.74 | 53.9 | Palliative (P) | 2017-04-22 | 2017-04-22 | Liposomal Doxorubicin 50mg/m2 | N | Y | 320017683 | LIPOSOMAL DOXORUBICIN |
| 320007256 | 320003699 | 1.68 | 57.8 | Palliative (P) | 2018-05-28 | 2018-10-05 | Cetuximab 7 day (Cycle 1) | 02 | Y | 320017787 | CETUXIMAB |
| 320007257 | 320003706 | 1.55 | 59.5 | Palliative (P) | 2019-10-16 | 2019-11-21 | Trial Unspecified | N | N | 320017944 | TRIAL |
| 320007258 | 320003717 | 1.72 | 111.9 | Palliative (P) | 2018-06-29 | 2018-06-29 | Trial Unspecified | N | N | 320018100 | TRIAL |
| 320007259 | 320003725 | 1.63 | 68.7 | Palliative (P) | 2017-06-23 | 2017-06-24 | WT SIOP 2002 01 post op Vinc alone | N | null | 320018237 | NOT MATCHED |
| 320007260 | 320006647 | null | 82.2 | Palliative (P) | 2017-01-03 | 2017-01-24 | Carboplatin + Liposomal Doxorubicin | N | N | 320018528 | CARBOPLATIN + LIPOSOMAL DOX |
| 320007261 | 320003756 | 1.55 | 60 | Palliative (P) | 2015-03-16 | 2015-03-26 | Carboplatin + Liposomal Doxorubicin | N | N | 320018820 | CARBOPLATIN + LIPOSOMAL DOX |
| 320007262 | 320003773 | 1.56 | 60.2 | Curative (C) | 2018-09-25 | 2019-01-25 | EW EuroEwing 2012 Arm B VC | 02 | N | 320019030 | NOT MATCHED |
| 320007263 | 320003776 | 1.59 | null | Palliative (P) | 2015-04-06 | 2015-04-22 | TEMOZOLOMIDE | 02 | N | 320019104 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 320007264 | 320003783 | 1.59 | 51.5 | Palliative (P) | 2013-05-15 | 2015-06-06 | Etoposide oral | N | N | 320019230 | ICON TRIAL |
| 320007265 | 320003788 | 1.46 | 71.7 | Palliative (P) | 2018-06-16 | 2018-08-04 | STS Rhabdo RMS 2005 Vin Cyclo | N | N | 320019266 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 320007266 | 320003791 | null | 79.5 | Palliative (P) | 2014-07-01 | 2015-07-27 | PCV | N | N | 320019296 | BEVACIZUMAB + CARBO + GEMCITABINE |
| 320007267 | 320003794 | 1.77 | 81.1 | Palliative (P) | 2014-07-07 | 2014-07-25 | CISPLATIN + GEMCITABINE | 02 | N | 320019304 | CARBOPLATIN + RT |
| 320007268 | 320003807 | 1.76 | 56.6 | Palliative (P) | 2018-03-02 | 2018-04-03 | Imatinib 400mg | N | Y | 320019453 | IMATINIB |
| 320007269 | 320003810 | 1.6 | 57.1 | Curative (C) | 2017-07-09 | 2017-07-21 | Trabectedin | 2 | N | 320019455 | VINBLASTINE |
| 320007270 | 320003827 | 1.52 | 61.1 | Palliative (P) | 2014-11-26 | 2015-05-05 | NIVOLUMAB | N | N | 320019736 | PEMBROLIZUMAB |
| 320007271 | 320003852 | 1.73 | 72.7 | Adjuvant (A) | 2017-06-11 | 2017-06-13 | Capecitabine (21days) + Carboplatin | 2 | N | 320020277 | FLUOROURACIL + MITOMYCIN + RT |
| 320007272 | 320003855 | null | 69 | Curative (C) | 2016-11-16 | 2016-12-01 | ICON8 TRIAL | N | N | 320020281 | DOCETAXEL |
| 320007273 | 320003866 | 1.61 | 54.6 | null | 2018-02-08 | 2018-02-11 | EMA | 02 | N | 320020416 | ICON8B TRIAL |
| 320007274 | 320003870 | 1.72 | 71.3 | Palliative (P) | 2014-06-05 | 2015-01-31 | Carboplatin + Etoposide iv&po | 2 | N | 320020419 | CARBOPLATIN + RT |
| 320007276 | 320003882 | 1.78 | 76.3 | Palliative (P) | 2015-08-07 | 2015-08-09 | TEMOZOLOMIDE | N | N | 320020652 | FLUOROURACIL + MITOMYCIN + RT |